Eiko Lifescience — 360° view

Eiko Lifescience, a company in the Specialty Chemicals industry, reported revenue of ₹18 crore and net profit of ₹1.56 crore for the September 2026 quarter.

Eiko Lifescience (BSE: EIKO) closed at ₹51.78 on 20 Nov 2026, down 2.5% over the past year. Its market capitalisation is ₹76 crore and it trades at 14.7 times earnings.

Share price
₹51.78 (20 Nov 2026)
Market cap
₹76 Cr (20 Nov 2026)
P/E
14.67 (20 Nov 2026)
Revenue
₹18 Cr (September 2026 quarter)
Net profit
₹2 Cr (September 2026 quarter)
ROCE
11.1% (FY26)
ROE
8.47% (FY26)
Book value
₹49.6 (FY26)
Dividend yield
0.00% (FY26)
52-week high / low
₹59.00 / ₹43.00 (20 Nov 2026)
1-year return
-2.5% (to 20 Nov 2026)
Sector
Commodities
Industry
Specialty Chemicals
Symbol
BSE: EIKO

Incorporated in 2021, Eiko LifeSciences Ltd manufacturing & sells Specialty Chemical and Fine Chemicals

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.